Who are Praxis Precision Medicines, Inc.'s major customers?

Praxis Precision Medicines, Inc. (PRAX) key customers include: BCPE, Rapport Therapeutics, Inc., Xenon Pharmaceuticals Inc.. View the full customer network at chainsifter.com/chain/PRAX.

What sector is Praxis Precision Medicines, Inc. in?

Praxis Precision Medicines, Inc. (PRAX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Praxis Precision Medicines, Inc. (PRAX): 5 Verified Supply Chain Relationships

0Suppliers

3Customers

2Debt Items

13Related Chains

Source-Backed Evidence Depth

Praxis Precision Medicines, Inc. (PRAX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

2Distinct source URLs

4High confidence

0.843Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Praxis Precision Medicines, Inc. Suppliers

No suppliers on recordPraxis Precision Medicines, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.

Praxis Precision Medicines, Inc. Customers

Ticker	Name	Confidence	Evidence
BCPE	BCPE	92%	The Company recorded the common stock sold to BCPE at its issuance date fair value of $ 38.95 per share, or $ 17.3 million in the aggregate
RAPP	Rapport Therapeutics, Inc.	72%	Reciprocal relationship from RAPP graph: Reciprocal relationship from PRAX graph: Reciprocal relationship from RAPP graph: into longer-term commercial supply agreements to fulfill and secure our prod…
XENE	Xenon Pharmaceuticals Inc.	72%	Reciprocal relationship from XENE graph: velopment and marketing efforts of our collaborators. • Our reliance on third parties to manufacture our product candidates may increase the risk that we will…

Praxis Precision Medicines, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
PRAX-DEBT	Debt stack $1.4M	90%	Market cache reports total debt of $1.4M.
PRAX-DEBT-11873	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.

Praxis Precision Medicines, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Praxis Precision Medicines, Inc..

Praxis Precision Medicines, Inc. Ownership

Holder	Name	Confidence	Evidence
PRAX-OWNER-PERCEPTIVE-ADVISORS-LLC	PERCEPTIVE ADVISORS LLC	90%	13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 300 tracked holders.

Praxis Precision Medicines, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
RAPP	Rapport Therapeutics, Inc.	100.00	1	['customer']
XENE	Xenon Pharmaceuticals Inc.	100.00	1	['customer']
BCPE	BCPE	63.48	1	['receiving']
ORANY	ORANGE	50.00	2
NAMSW	NewAmsterdam Pharma Co N.V.	50.00	2
SUPN	Supernus Pharmaceuticals, Inc.	50.00	2
ANRO	Alto Neuroscience, Inc.	50.00	2
NMRA	Neumora Therapeutics, Inc.	50.00	2
LXRX	Lexicon Pharmaceuticals, Inc.	50.00	2
NPCE	NeuroPace, Inc.	50.00	2
NBIX	Neurocrine Biosciences, Inc.	50.00	2
AXSM	Axsome Therapeutics, Inc.	50.00	2
BHC	Bausch Health Companies Inc.	50.00	2

Praxis Precision Medicines, Inc. Supply Chain